Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I saw that as well. Only 1 note remaining and at these prices that will be extinguished in a few days. It also isn't due until later this year so very likely it could be paid off as well rather converting. In any case, I was very pleased to see the painful dilution that plagued this stock for a while now is clearly reaching its end state. Now with sales and a FDA decision on their device pending, this is set up for a big move.
And when the FDA gives the approval on their 510K device application, KABOOOOOOOMMMM! .05-.10 on that news.
Gonna be a fun month of June here IMO
Finally breaking through .022 area resistance. Next area should be .026ish.
Pressure is building ahead of a .022 long term trendline breakout. I think next week we see this make a major move up towards the .03 area.
Saw that yesterday and thought it was very encouraging for this next round of testing. We shall see if the results are positive this next time.
I'm holding. Will wait another month to see if this new testing company can address whatever perceived issues there was with the prior testing company and their approach/procedure.
Correct. They enacted their extension to give them more time to resolve this issue. I think the big question is can they and then resubmit for a new test with a different testing company.
I think your comment is a bit misleading. It wasn’t rejected by the FDA, but rather by FDA consultants just like the company we’re using today.
They're terrible at shareholder communication. Even with the new IR, she is pretty clueless and it sounds like Tom keeps her in the dark like the rest of us. Last we heard was that the testing was supposed to be wrapped up and results were to be provided a week ago. Did that happen? Who knows. Is it possible they did get those back and are now heads down reviewing everything and making sure the application is ready to go? Possibly. Would be great if they announced next week that it was back with the FDA for review. That would really generate some excitement and finally put this on a countdown.
I mean it's hard to argue with you because that's how I am looking at this now too. They tweeted about having the testing results completed and results in hand by the end of last week. Today? Nothing. No tweet on whether that happened or if they ran into more delays. The fact they aren't responding to emails on it doesn't look good either. They need to address this or this will fall down to .01s again.
Yeah, I know. I am here for the FDA approval though, and it's been dragging since late last year of just getting this back into the FDA's court. Here we are in late March and still no definitive word on whether they have everything ready to submit or not. Just gets frustrating dealing with this company because they put these self imposed timelines out there and then never execute to them.
It's not with the FDA yet. That is what is bugging me about the news today. It's these periods where they say something will happen (e.g. testing results would be provided back last week) and then they just go dark until it's finally at a point where the concede a setback. Seen it too many times here and hoping this isn't going to happen again. I can't stomach another move to the .011 support area.
Yeah, but now they’re being quiet again on the testing and where things stand there. Hope it’s not another setback at this point but sorta surprised they haven’t followed up on last tweet about it saying results would be provided at the end of last week.
Thinking the news we see at some point this week is going to be FDA submission related. Just have a hunch. I think they got the test results back last week and that is why you saw the spike in buying interest. It's very likely the 501K consulting company is already reviewing and doing their final pass of the documents with the expectation that all will be resubmitted back to the FDA by the end of the week.
Looking good. Slow and steady.
Nice green but somewhat sideways action. This is great for building a nice base here in the .02 area ahead of upcoming catalysts. Stock should move up to .025-.03 range on FDA resubmission news. And quite frankly, I would like to see it trade sideways while the FDA reviews. If and when FDA approval happens, .05-.10 is my initial target area for the spike on what I assume will be large volume. Then plan to hold a chunk for earnings forecasts and potential buyout from a bigger fish in the CPAP space.
Nice little move up earlier this morning. I expect it to continue creeping up over the next several weeks. Should push above .02 area on news submitted back to FDA for decision.
One would think. They’re going to be out of excuses at this point, at least anything anyone will actually believe. This is really their last chance to prove they’re legit and this 501K is moving forward to a decision. The biggest update I’m waiting for is that everything has been submitted and the FDA is on the clock. That happens and I think you’ll see renewed interest, volume, etc.
Bottom in with solid support here at .012 now. This will creep upwards over the next couple of weeks.
Yeah, I think that's pretty spot on. I do think this will see a bump up though once they get it back in front of the FDA, which could be anywhere 2-3 weeks IMO.
This is trading like the dilution has finally come to an end. Seems to be just light trading and purely retail. Should start to trend up heading into next week when the testing results are received. Then hopefully just a week or two tops to do one more final review before submitting to the FDA.
Fingers crossed the results are in line with what they expected (i.e. successful) and they can submit within a week or so after confirming everything is in order.
Decent close although I think the jury is still out on whether today's hammer is the turning point where this start moving back up. Will see how the rest of the week goes and see what if any updates come out from IR.
Yes, I did see that mentioned in a follow up tweet that they can use the extension. My hope is that the retest is really all that is needed since the post test analysis was based on it being done correctly, which after this should now be the case. They shouldn't have to redo everything like they did after doing the condensation testing, at least that is how I was looking at it. My hope is back in front of FDA by the end of this month, with late April early May as a final decision date.
Bought back in low .01s, will see how this plays out over the coming weeks. If they can get this back in front of the FDA, I think it should start trending up from there until a decision is eventually made.
Agreed. I'm happy to keep accumulating down here at the .02 range too. This will pop soon enough.
Almost back in buying range. Gonna wait a few more days and see if it dumps down to .01 area.
Grabbed a starter here today. Will add any sub .02 dips from here on out.
And now they are saying they need 3 more weeks haha. More like 3 more months. What a joke this company is.
Incompetent management, dilution, lack of follow up on the 501k application, empty promises, worthless investor relations...those are just a few of the things that come to mind.
What a turd. This is what happens when you dangle the carrot for so long but fail to deliver on anything.
That’s about what I figured. They need to pay off the remaining notes with the capital they just raised. They do that and keep the share structure tight moving forward, could do well in the coming months. Of course this assumes they finally resubmit to the FDA soon.
Agreed. Knowing that any further dilution wasn't in the cards would be a hugely positive event for RMSL. Combine that with an impending FDA decision and I could easily see rising up until then in anticipation. But that all hinges on what the company used all those proceeds for. You would think ridding yourself of harmful notes would be at the top of the list.
With $4M received from the Reg A, why would they not want to rid themselves of the convertible notes once and for all and communicate to shareholders that they are now fully funded with no more dilution coming via notes. I mean doing that would go a long way and really set things up for a nice move.
Meanwhile, STXG parked at .0187 and selling shares.
Yes, unfortunately it seems that's all this company sells is shares. Curious to see how bad it's been since early January when the transfer agent updates the numbers. I think we could see a big dip back down to .01 area if the O/S shows a large increase, which judging by the MMs like STXG and how much they have been dumping, could be a big number. Company paid shills are out there on Twitter saying zero dilution. Such a joke.
Market Maker STXG is diluting. It's very obvious to see. O/S numbers I think are going to be bad next week. I can see this dipping down to the low .01s again. This is again turning into the same RMSL I remember that just dilutes and makes empty promises. Thought they would have turned things around this time but they (and their new IR) are just nothing but talk and zero results.
Yeah, not sure what is going on but they are definitely still diluting shares. Pretty disappointing.
Seems this company sells more shares than anything related to sleep apnea products.
I believe it’s dilution